Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Polaryx Therapeutics, Inc. (PLYX)
Company Research
Source: Yahoo! Finance
biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announces that members of the executive team will be participating in the 25th Annual Needham Virtual Healthcare Conference. Format : Polaryx management will host one-on-one investor meetings as well as a group presentation Dates: One-on-one meetings: Monday, April 13, 2026 through Thursday, April 16, 2026 Group presentation: Thursday, April 16, 2026 at 10:15 a.m. ET To schedule a meeting, please contact your Needham & Company, LLC representative. Live webcasts of the presentations will be available under “ News and Events ” in the Investors Relations section of the Company's website at https://investors.polaryx.com/ . Replays of the webcasts will be archived and available following the events. About Polaryx Therapeutics Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing patient-friendly small molecule and
Show less
Read more
Impact Snapshot
Event Time:
PLYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLYX alerts
High impacting Polaryx Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PLYX
News
- Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric CareGlobeNewswire
- Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- Polaryx Therapeutics Receives FDA Fast Track Designation for PLX-200 for Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease) [Yahoo! Finance]Yahoo! Finance
- Polaryx Therapeutics Receives FDA Fast Track Designation for PLX-200 for Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)GlobeNewswire
- Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy EventsGlobeNewswire
PLYX
Sec Filings
- 3/24/26 - Form 10-K
- 2/20/26 - Form 4
- 2/5/26 - Form SCHEDULE
- PLYX's page on the SEC website